Skip to main content
Type at least 3 characters

524 articles

Original Research

Published on 24 Jun 2022

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice

in Cardiovascular Endocrinology

  • Luis M. Pérez-Belmonte
  • Jaime Sanz-Cánovas
  • María D. García de Lucas
  • Michele Ricci
  • Beatriz Avilés-Bueno
  • Lidia Cobos-Palacios
  • Miguel A. Pérez-Velasco
  • Almudena López-Sampalo
  • M. Rosa Bernal-López
  • Sergio Jansen-Chaparro
Frontiers in Endocrinology
doi 10.3389/fendo.2022.851035
  • 12,753 views
  • 18 citations